These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
731 related articles for article (PubMed ID: 26389119)
1. Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge. Piersma B; Bank RA; Boersema M Front Med (Lausanne); 2015; 2():59. PubMed ID: 26389119 [TBL] [Abstract][Full Text] [Related]
2. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer. Noguchi S; Saito A; Nagase T Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366 [TBL] [Abstract][Full Text] [Related]
3. Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switching. Lüönd F; Pirkl M; Hisano M; Prestigiacomo V; Kalathur RK; Beerenwinkel N; Christofori G Life Sci Alliance; 2022 Feb; 5(2):. PubMed ID: 34819356 [TBL] [Abstract][Full Text] [Related]
4. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation. Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835 [TBL] [Abstract][Full Text] [Related]
5. YAP/TAZ Are Mechanoregulators of TGF- Szeto SG; Narimatsu M; Lu M; He X; Sidiqi AM; Tolosa MF; Chan L; De Freitas K; Bialik JF; Majumder S; Boo S; Hinz B; Dan Q; Advani A; John R; Wrana JL; Kapus A; Yuen DA J Am Soc Nephrol; 2016 Oct; 27(10):3117-3128. PubMed ID: 26961347 [TBL] [Abstract][Full Text] [Related]
6. Crosslinked Extracellular Matrix Stiffens Human Trabecular Meshwork Cells Via Dysregulating β-catenin and YAP/TAZ Signaling Pathways. Yemanyi F; Vranka J; Raghunathan VK Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):41. PubMed ID: 32832971 [TBL] [Abstract][Full Text] [Related]
7. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis. Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139 [TBL] [Abstract][Full Text] [Related]
8. Yap/Taz Deletion in Gli Liang M; Yu M; Xia R; Song K; Wang J; Luo J; Chen G; Cheng J J Am Soc Nephrol; 2017 Nov; 28(11):3278-3290. PubMed ID: 28768710 [TBL] [Abstract][Full Text] [Related]
9. The signaling protein Wnt5a promotes TGFβ1-mediated macrophage polarization and kidney fibrosis by inducing the transcriptional regulators Yap/Taz. Feng Y; Liang Y; Zhu X; Wang M; Gui Y; Lu Q; Gu M; Xue X; Sun X; He W; Yang J; Johnson RL; Dai C J Biol Chem; 2018 Dec; 293(50):19290-19302. PubMed ID: 30333225 [TBL] [Abstract][Full Text] [Related]
11. Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function. Mia MM; Cibi DM; Ghani SABA; Singh A; Tee N; Sivakumar V; Bogireddi H; Cook SA; Mao J; Singh MK Cardiovasc Res; 2022 Jun; 118(7):1785-1804. PubMed ID: 34132780 [TBL] [Abstract][Full Text] [Related]
12. Carvacrol ameliorates the progression of liver fibrosis through targeting of Hippo and TGF-β signaling pathways in carbon tetrachloride (CCl Mohseni R; Karimi J; Tavilani H; Khodadadi I; Hashemnia M Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):163-171. PubMed ID: 30706740 [No Abstract] [Full Text] [Related]
13. The role of angiotensin II activation of yes-associated protein/PDZ-binding motif signaling in hypertensive cardiac and vascular remodeling. Xu Q; Zhuo K; Zhang X; Zhen Y; Liu L; Zhang L; Gu Y; Jia H; Chen Q; Liu M; Dong J; Zhou MS Eur J Pharmacol; 2024 Jan; 962():176252. PubMed ID: 38061470 [TBL] [Abstract][Full Text] [Related]
14. [YAP/TAZ regulates multiple signal pathways in the genesis and development of hepatic fibrosis]. Pan H; Liao M; Song P Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 43(3):313-319. PubMed ID: 29701195 [TBL] [Abstract][Full Text] [Related]
15. Reduction of Cardiac Fibrosis by Interference With YAP-Dependent Transactivation. Garoffolo G; Casaburo M; Amadeo F; Salvi M; Bernava G; Piacentini L; Chimenti I; Zaccagnini G; Milcovich G; Zuccolo E; Agrifoglio M; Ragazzini S; Baasansuren O; Cozzolino C; Chiesa M; Ferrari S; Carbonaro D; Santoro R; Manzoni M; Casalis L; Raucci A; Molinari F; Menicanti L; Pagano F; Ohashi T; Martelli F; Massai D; Colombo GI; Messina E; Morbiducci U; Pesce M Circ Res; 2022 Jul; 131(3):239-257. PubMed ID: 35770662 [TBL] [Abstract][Full Text] [Related]
16. Hippo and TGF-β interplay in the lung field. Saito A; Nagase T Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L756-67. PubMed ID: 26320155 [TBL] [Abstract][Full Text] [Related]
17. New Insights into Hippo/YAP Signaling in Fibrotic Diseases. Mia MM; Singh MK Cells; 2022 Jun; 11(13):. PubMed ID: 35805148 [TBL] [Abstract][Full Text] [Related]
18. Mechanosensor YAP cooperates with TGF-β1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis. Ragazzini S; Scocozza F; Bernava G; Auricchio F; Colombo GI; Barbuto M; Conti M; Pesce M; Garoffolo G Acta Biomater; 2022 Oct; 152():300-312. PubMed ID: 36055606 [TBL] [Abstract][Full Text] [Related]
19. NUAK1 promotes organ fibrosis via YAP and TGF-β/SMAD signaling. Zhang T; He X; Caldwell L; Goru SK; Ulloa Severino L; Tolosa MF; Misra PS; McEvoy CM; Christova T; Liu Y; Atin C; Zhang J; Hu C; Vukosa N; Chen X; Krizova A; Kirpalani A; Gregorieff A; Ni R; Chan K; Gill MK; Attisano L; Wrana JL; Yuen DA Sci Transl Med; 2022 Mar; 14(637):eaaz4028. PubMed ID: 35320001 [TBL] [Abstract][Full Text] [Related]
20. TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts. Vallée A; Lecarpentier Y Cell Biosci; 2019; 9():98. PubMed ID: 31827764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]